Symbiotec Pharmalab IPO Day 2: GMP Signals 34.41% Listing Gain; Check Subscription Status

How 1 sources are covering this

• NDTVCenter·1h ago

  Symbiotec Pharmalab IPO Day 2: GMP Signals 34.41% Listing Gain; Check Subscription Status

  Symbiotec Pharmalab IPO was fully subscribed on Day 2, with GMP signalling a 34.41% potential listing gain as investor demand remains strong.

  Read at NDTV →